Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Cancer Research UK has today announced the appointment of Professor Ketan (KJ) Patel FRS FMedSci (Radcliffe Department of Medicine) as its new Chief Scientist.

CRUK appoints new chief scientist

Alongside his new role at Cancer Research UK, Professor Ketan (KJ) Patel will continue as the Director of both the MRC Weatherall Institute for Molecular Medicine (MRC WIMM) and the MRC Molecular Haematology Unit (MRC MHU).

Beginning in the role this October, Professor Patel will provide scientific leadership for the charity’s activities and ambitions, joining at an important time following the launch of the organisation’s new long-term strategy earlier this year that puts discovery science at the heart of its work.

Alongside his Directorship roles at the MRC WIMM and MRC MHU, Professor Patel leads the Two tier protection and metabolic genotoxicity during blood production Research Group at the MRC Molecular Haematology Unit whose research focuses on the molecular basis of inherited genomic instability and the role it plays in the biology of stem cells, particularly those that make blood.

Read the full story on the Radcliffe Department of Medicine